Westchester Capital Management, Inc. Abb Vie Inc. Transaction History

Westchester Capital Management, Inc.

$411 Million
Q3 2024

A detailed history of Westchester Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Westchester Capital Management, Inc. holds 105,590 shares of ABBV stock, worth $19 Million. This represents 5.07% of its overall portfolio holdings.

Number of Shares

105,590

Previous 106,695 1.04%

Holding current value

$19 Million

Previous $18.3 Million 13.94%

% of portfolio

5.07%

Previous 4.63%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$163.84 - $199.33 $181,043 - $220,259	-1,105 Reduced 1.04%	105,590 $20.9 Million
Q2 2024 Jul 26, 2024	BUY	$154.79 - $180.76 $806,920 - $942,301	5,213 Added 5.14%	106,695 $18.3 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $285,278 - $325,048	-1,785 Reduced 1.73%	101,482 $18.5 Million
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $114,208 - $128,625	-830 Reduced 0.8%	103,267 $16 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $36,870 - $42,683	276 Added 0.27%	104,097 $15.5 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $22,924 - $28,527	173 Added 0.17%	103,821 $14 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $387,699 - $446,493	-2,681 Reduced 2.52%	103,648 $16.5 Million
Q4 2022 Feb 08, 2023	SELL	$138.31 - $165.87 $585,327 - $701,961	-4,232 Reduced 3.83%	106,329 $17.2 Million
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $26,036 - $29,862	-194 Reduced 0.18%	110,561 $14.8 Million
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $20,092 - $25,544	-146 Reduced 0.13%	110,755 $17 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $160,355 - $198,956	-1,215 Reduced 1.08%	110,901 $18 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $240,858 - $304,755	-2,242 Reduced 1.96%	112,116 $15.2 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $40,964 - $46,500	-385 Reduced 0.34%	114,358 $12.3 Million
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $181,697 - $202,421	-1,727 Reduced 1.48%	114,743 $12.9 Million
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $54,423 - $59,913	-532 Reduced 0.45%	116,470 $12.6 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $76,143 - $102,801	-946 Reduced 0.8%	117,002 $12.5 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $11,941 - $14,015	-139 Reduced 0.12%	117,948 $10.3 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $38,005 - $50,857	518 Added 0.44%	118,087 $11.6 Million
Q1 2020 May 01, 2020	SELL	$64.5 - $97.79 $90,106 - $136,612	-1,397 Reduced 1.17%	117,569 $8.96 Million
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $230,743 - $288,709	3,199 Added 2.76%	118,966 $10.5 Million
Q3 2019 Nov 05, 2019	BUY	$62.98 - $75.72 $148,191 - $178,169	2,353 Added 2.07%	115,767 $8.77 Million
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $541,039 - $691,575	8,235 Added 7.83%	113,414 $8.25 Million
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $126,509 - $148,895	-1,640 Reduced 1.54%	105,179 $8.48 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $281,349 - $346,980	-3,614 Reduced 3.27%	106,819 $9.85 Million
Q3 2018 Nov 06, 2018	SELL	$88.91 - $98.84 $25,783 - $28,663	-290 Reduced 0.26%	110,433 $10.4 Million
Q2 2018 Aug 01, 2018	SELL	$89.78 - $106.23 $46,057 - $54,495	-513 Reduced 0.46%	110,723 $10.3 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $644,898 - $863,578	-7,009 Reduced 5.93%	111,236 $10.5 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $2.62 Million - $2.87 Million	-29,253 Reduced 19.83%	118,245 $11.4 Million
Q3 2017 Oct 26, 2017	BUY	$69.85 - $89.22 $10.3 Million - $13.2 Million	147,498	147,498 $13.1 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westchester Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westchester Capital Management, Inc. with notifications on news.

Account

Westchester Capital Management, Inc. Abb Vie Inc. Transaction History